DRMAW vs DVN
Dermata Therapeutics Inc. Warrant (DRMAW) versus Devon Energy Corporation (DVN) — a side-by-side from cached financials, not a winner call.
Dermata Therapeutics Inc. Warrant (DRMAW) common stock listed on NASDAQ.
Devon Energy Corporation (DVN) is a oil & gas e&p company listed on US.
DRMAW does not have a complete income-statement cache yet.
Latest reported DVN revenue for 2026-06-30 was $7.42B. Net income was $1.91B. Revenue was up 94.8% from 2026-03-31 to 2026-06-30. DVN currently screens at market cap $22.42B and trailing P/E 7.4.
DRMAW currently screens at market cap $0. DVN currently screens at market cap $22.42B and trailing P/E 7.4.
Not investment advice. Open the DRMAW and DVN stock pages for the full models.
Not investment advice.